Primitive reflexes in a case-control study of patients with advanced human immunodeficiency virus type 1

I W Tremont-Lukats1, G M Teixeira, D E Hernández

  • 1Department of Neurology, University of Wisconsin Hospital and Clinics, Madison 53792-5132, USA. itremont@facstaff.wisc.edu

Journal of Neurology
|August 27, 1999
PubMed

Insights

Primitive reflexes (PR) were significantly more frequent in patients with human immunodeficiency virus type 1 (HIV-1) infection, indicating a potential link to cognitive decline in advanced stages of the disease.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Neuroimmunology

Background:

  • Acquired immunodeficiency syndrome (AIDS) can affect neurological function.
  • Primitive reflexes (PR) are typically present in infants and disappear with neurological maturation.
  • The presence of PR in adults may indicate underlying neurological dysfunction.

Purpose of the Study:

  • To estimate the frequency of nine primitive reflexes (PR) in patients with human immunodeficiency virus type 1 (HIV-1) infection.
  • To assess the clinical value of PR in patients with advanced HIV-1 infection.
  • To explore the association between PR and cognitive impairment in HIV-1-infected individuals.

Main Methods:

  • A cross-sectional study involving 78 patients with HIV-1 infection (WHO clinical stage 3 or 4) and 81 seronegative controls.
  • Standardized neurological examination to assess nine primitive reflexes.
  • Mini-Mental State Examination (MMSE) to evaluate cognitive function.

Main Results:

  • Primitive reflexes were found in 36% of HIV-1 patients versus 0% of controls (P<0.0001).
  • PR were 2-36 times more frequent in HIV-1 patients, particularly glabellar, snout, Rossolimo, and digital signs.
  • 92% of HIV-1 patients had at least two PR compared to 8% of controls (P<0.0001).

Conclusions:

  • Primitive reflexes are significantly associated with cognitive decline in patients with advanced HIV-1 infection.
  • PR may serve as potential indicators of HIV-1-associated cognitive/motor complex and neurocognitive disorders.
  • Further research with larger cohorts and multivariate analysis is recommended to validate PR as biomarkers.